These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Embodiment and biographical disruption in people living with HIV/AIDS (PLWHA). Alexias G; Savvakis M; Stratopoulou Ι AIDS Care; 2016; 28(5):585-90. PubMed ID: 26644042 [TBL] [Abstract][Full Text] [Related]
45. Localized scleroderma: a clinical study at a single center in Korea. Noh JW; Kim J; Kim JW Int J Rheum Dis; 2013 Aug; 16(4):437-41. PubMed ID: 23992265 [TBL] [Abstract][Full Text] [Related]
46. [Social identity of people with rare conditions and the lack of diagnosis: contributions based on Hall, Honneth and Jutel]. Gomes JS Cien Saude Colet; 2019; 24(10):3701-3708. PubMed ID: 31576999 [TBL] [Abstract][Full Text] [Related]
47. Symptoms of disease and psychological adaptation in Brazilian scleroderma patients. Leite CC; Maia  Rev Bras Reumatol; 2013; 53(5):405-11. PubMed ID: 24316897 [TBL] [Abstract][Full Text] [Related]
48. Cognitive-behavioural therapy targeting fear of progression in an interdisciplinary care program: a case study in systemic sclerosis. Kwakkenbos L; Willems LM; van den Hoogen FH; van Lankveld WG; Beenackers H; van Helmond TF; Becker ES; van den Ende CH J Clin Psychol Med Settings; 2014 Dec; 21(4):297-312. PubMed ID: 25358547 [TBL] [Abstract][Full Text] [Related]
49. [Scleroderma: oral manifestations]. Moniaci D; Rivetti M; Flecchia G; Ferrari Parabita S; Re G Minerva Stomatol; 1989 Feb; 38(2):295-8. PubMed ID: 2651876 [TBL] [Abstract][Full Text] [Related]
50. Living with chronic illness: the interface of stigma and normalization. Joachim G; Acorn S Can J Nurs Res; 2000 Dec; 32(3):37-48. PubMed ID: 11928132 [TBL] [Abstract][Full Text] [Related]
52. [Psychiatric manifestations of systemic sclerosis]. Baubet T; Brunet M; Garcia De La Peña-Lefebvre P; Taïeb O; Moro MR; Guillevin L; Mouthon L Ann Med Interne (Paris); 2002 Jun; 153(4):237-41. PubMed ID: 12218889 [TBL] [Abstract][Full Text] [Related]
53. Making sense of chronic illness--a therapeutic approach. Jacobi S; MacLeod R J Prim Health Care; 2011 Jun; 3(2):136-41. PubMed ID: 21625662 [TBL] [Abstract][Full Text] [Related]
54. Paraneoplastic Scleroderma: Are There Any Clues? Jedlickova H; Durčanská V; Vašků V Acta Dermatovenerol Croat; 2016 Apr; 24(1):78-80. PubMed ID: 27149136 [TBL] [Abstract][Full Text] [Related]
55. [Atypical scleroderma erythemato-pigmented, in visible and invisible bands, confirmed by a scleroderma in drops]. GOUGEROT H; GRUPPER Ann Dermatol Syphiligr (Paris); 1946 Mar; 6():124. PubMed ID: 20989576 [No Abstract] [Full Text] [Related]
57. Localized and systemic forms of scleroderma in adults and children . Atzeni F; Bardoni A; Cutolo M; Hunzelmann N; Krieg T; Martini G; Montecucco C; Olski TM; Secchi ME; Valentini G; Zulian F; Sarzi-Puttini P Clin Exp Rheumatol; 2006; 24(1 Suppl 40):S36-45. PubMed ID: 16466623 [TBL] [Abstract][Full Text] [Related]
58. Linear scleroderma: a Neuman nursing perspective. Fuller CC; Hartley B J Pediatr Nurs; 2000 Jun; 15(3):168-74. PubMed ID: 10897554 [TBL] [Abstract][Full Text] [Related]
59. Scleroderma with an update about clinico-pathological correlation. Rongioletti F; Ferreli C; Atzori L; Bottoni U; Soda G G Ital Dermatol Venereol; 2018 Apr; 153(2):208-215. PubMed ID: 29368844 [TBL] [Abstract][Full Text] [Related]
60. To tell or not to tell: A systematic review of the disclosure practices of children living with epilepsy and their parents. Benson A; O'Toole S; Lambert V; Gallagher P; Shahwan A; Austin JK Epilepsy Behav; 2015 Oct; 51():73-95. PubMed ID: 26262936 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]